WARREN, N.J. (AP) — WARREN, N.J. (AP) — Aquestive Therapeutics Inc. (AQST) on Monday reported a loss of $22.9 million in its first quarter.
On a per-share basis, the Warren, New Jersey-based company said it had a loss of 24 cents.
The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The specialty pharmaceutical company posted revenue of $8.7 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $12.1 million.
In the final minutes of trading on Monday, the company’s shares hit $2.87. A year ago, they were trading at $3.09.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AQST at https://www.zacks.com/ap/AQST
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
